Lipoprotein(a) and Cardiovascular Diseases-Reference-Cited by-同舟云学术

Lipoprotein(a) and Cardiovascular Diseases

Published:2021-07-27 Issue:4 Volume:326 Page:352
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Miksenas Hannah¹,Januzzi James L.¹²,Natarajan Pradeep¹²³

Affiliation:

1. Division of Cardiology, Massachusetts General Hospital, Boston

2. Department of Medicine, Harvard Medical School, Boston, Massachusetts

3. Program in Medical and Population Genetics, Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, Massachusetts

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2781946/jama_miksenas_2021_it_210018_1639510359.26729.pdf

Reference10 articles.

1. Lipids and lipoproteins in 2020.;Ference;JAMA,2020

2. A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies.;Tsimikas;J Am Coll Cardiol,2017

3. Clinical utility of lipoprotein(a) and LPA genetic risk score in risk prediction of incident atherosclerotic cardiovascular disease.;Trinder;JAMA Cardiol,2020

4. Phenotypic characterization of genetically lowered human lipoprotein(a) levels.;Emdin;J Am Coll Cardiol,2016

5. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.;Grundy;J Am Coll Cardiol,2019

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated lipoprotein(a) levels: A crucial determinant of cardiovascular disease risk and target for emerging therapies;Current Problems in Cardiology;2024-08

2. Temporal variability of Lp(a) in clinically stable patients: Implications for cardiovascular risk assessment;Medicina Clínica;2024-07

3. Lipoprotein(a) and long-term in-stent restenosis after percutaneous coronary intervention;European Journal of Preventive Cardiology;2024-06-24

4. Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure: The CASABLANCA Study;Journal of the American Heart Association;2024-06-18

5. Myocardial Bridging-Induced Acute Coronary Syndrome: A Bridge Too Far;Cureus;2024-06-10